Category: Press Release

Home Press Release
Post

GeoVax Advances Mpox Vaccine Development Amid Rising Global Cases

GeoVax Labs, Inc., a clinical-stage biotechnology company, is making significant strides in the development of its GEO-MVA vaccine for Mpox and smallpox, addressing the urgent need for diversified vaccine options amidst rising global cases. The company has received favorable regulatory feedback from the European Medicines Agency (EMA), setting the stage for an expedited path toward...

Post

US Nuclear Corp Reports Significant Growth in Overhoff Technology Segment

US Nuclear Corp (OTC: UCLE) has announced a remarkable 55% surge in Overhoff Technology’s gross profit, reaching nearly $1.2 million on revenues exceeding $2 million, which constitutes 93% of total sales. This financial uptick is attributed to the recent migration of manufacturing and production to the Overhoff Technology facility in Milford, OH, a move that...

Post

Aristocrat Group Corporation Secures Exclusive Licensing Agreement with Merica Beer

Aristocrat Group Corporation (OTC: ASCC) has entered into a strategic licensing agreement with Merica Beer, a brand celebrated for its American identity and consumer appeal, granting ASCC exclusive rights to manufacture, market, and distribute Merica Beer products nationwide. This partnership is poised to tap into the lucrative $120+ billion U.S. beer market, focusing on expanding...

Post

Nutriband Inc. Advances in Opioid Safety with AVERSA(TM) Fentanyl Milestone

Nutriband Inc. (NASDAQ: NTRB) has recently completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a pivotal step toward FDA approval, in collaboration with Kindeva Drug Delivery. This development underscores the company’s commitment to redefining opioid safety amidst the ongoing crisis. AVERSA(TM) Fentanyl, protected by international patents, represents a breakthrough in abuse-deterrent technology, potentially addressing a critical gap...

Post

Metavesco Completes Significant Share Buyback to Enhance Shareholder Value

Metavesco, Inc. (OTC: MVCO), a diversified holding company, has announced the completion of a buyback of 200 million shares of its common stock, marking a significant step in its strategy to enhance shareholder value. The repurchased shares are set to be returned to the treasury for cancellation, reducing the company’s issued and outstanding common stock...

Post

Goliath Resources Reports Significant Gold Findings at Golddigger Property, Expands 2025 Drill Program

Goliath Resources Limited, a portfolio company of McEwen Mining Inc., has announced the discovery of six new visible gold occurrences within a 96.5-meter mineralized interval from drill hole GD-25-302 at the Bonanza Zone of its Golddigger Property. Located in British Columbia’s Golden Triangle, this discovery is part of an ongoing drill program targeting a deep...

Post

Tonix Pharmaceuticals’ TNX-1700 Shows Promise in Enhancing Immunotherapy for Gastric Cancer

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) has recently published preclinical data in Cancer Cells that highlights the potential of its fusion protein candidate, mTNX-1700, to enhance immunotherapy in gastric cancer. The study, conducted in collaboration with Columbia University Medical School, demonstrated that mTNX-1700, which combines murine trefoil factor-2 (mTFF2) and murine serum albumin, significantly increased...

Post

Nightfood Holdings Inc. (NGTF) Pioneers AI and Robotics in Hospitality Sector

Nightfood Holdings Inc. (OTCQB: NGTF) is making significant strides in the hospitality sector by integrating artificial intelligence and robotics to address labor shortages and enhance guest experiences. The company’s recent activities highlight its commitment to leading the industry through innovative solutions and strategic acquisitions. Notably, Nightfood has announced a Letter of Intent (LOI) to acquire...

Post

Oragenics Inc. Secures $16.5 Million to Advance Intranasal Concussion Therapy

Oragenics Inc. (NYSE American: OGEN), a clinical-stage biotechnology company, has successfully closed a public offering of Series H Convertible Preferred Stock and Warrants, amassing approximately $16.5 million in gross proceeds. This financial achievement underscores the company’s commitment to advancing its intranasal therapeutics for neurological disorders, particularly its ONP-002 treatment for concussions. The offering involved the...